JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.03% |
| 2 | Healthcare | 12.52% |
| 3 | Financials | 10.5% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNV
1701
DELISTED
Synovus
SNV
| $16.5M | ﹤0.01% |
458,677
+20,498
| +5% | +$848K |
|
1702
Rivian
RIVN
$23.1B
| $16.5M | ﹤0.01% |
642,288
-480,449
| -43% | -$15M |
|
1703
CALL
Philip Morris
PM
$290B
| $16.5M | ﹤0.01% |
167,000
-41,400
| -20% | -$4.22M |
|
1704
Medpace
MEDP
$16.7B
| $16.5M | ﹤0.01% |
110,134
-7,674
| -7% | -$1.11M |
|
1705
Bruker
BRKR
$9.03B
| $16.5M | ﹤0.01% |
262,499
+13,911
| +6% | +$853K |
|
1706
PUT
Altria Group
MO
$107B
| $16.5M | ﹤0.01% |
394,100
+191,400
| +94% | +$9.91M |
|
1707
PUT
Marathon Petroleum
MPC
$97.8B
| $16.4M | ﹤0.01% |
200,000
+163,300
| +445% | +$15.3M |
|
1708
PUT
FedEx
FDX
$77.3B
| $16.4M | ﹤0.01% |
72,500
+40,000
| +123% | +$8.54M |
|
|
LKFT
1709
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
| $16.4M | ﹤0.01% |
294,429
-5,281
| -2% | -$313K |
|
1710
eGain
EGAN
$200M
| $16.4M | ﹤0.01% |
1,684,639
+543,228
| +48% | +$5.42M |
|
|
CUK
1711
DELISTED
Carnival PLC
CUK
| $16.4M | ﹤0.01% |
2,078,373
+89,561
| +5% | +$1.21M |
|
|
DOCU
1712
PUT
DocuSign
DOCU
$11.1B
| $16.4M | ﹤0.01% |
+286,000
| New | +$23.2M |
|
|
SRRA
1713
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $16.4M | ﹤0.01% |
+298,323
| New | +$15.7M |
|
1714
Polaris
PII
$3.9B
| $16.4M | ﹤0.01% |
165,151
+46,173
| +39% | +$4.78M |
|
1715
Cloudflare
NET
$111B
| $16.4M | ﹤0.01% |
374,764
+220,741
| +143% | +$15.9M |
|
1716
Markel Group
MKL
$22.8B
| $16.4M | ﹤0.01% |
12,670
-603
| -5% | -$827K |
|
1717
LivaNova
LIVN
$4.45B
| $16.4M | ﹤0.01% |
262,062
-12,396
| -5% | -$878K |
|
1718
Five Below
FIVE
$13.2B
| $16.4M | ﹤0.01% |
144,203
+16,851
| +13% | +$2.42M |
|
1719
MYR Group
MYRG
$5.18B
| $16.4M | ﹤0.01% |
185,602
-17,945
| -9% | -$1.57M |
|
1720
Tronox
TROX
$985M
| $16.3M | ﹤0.01% |
972,575
-166,003
| -15% | -$3.01M |
|
1721
GATX Corp
GATX
$6.34B
| $16.3M | ﹤0.01% |
172,639
+104,079
| +152% | +$11.1M |
|
1722
PUT
Thermo Fisher Scientific
TMO
$223B
| $16.2M | ﹤0.01% |
29,900
-9,000
| -23% | -$4.95M |
|
1723
CALL
Deutsche Bank
DB
$72.4B
| $16.2M | ﹤0.01% |
1,858,400
-7,274,800
| -80% | -$77.7M |
|
1724
Nelnet
NNI
$4.52B
| $16.2M | ﹤0.01% |
189,527
+106,758
| +129% | +$8.87M |
|
1725
Inspire Medical Systems
INSP
$1.68B
| $16.1M | ﹤0.01% |
88,395
+18,424
| +26% | +$3.67M |
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.